Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Impax Laboratories, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 33.76||$ 51.42|
|Low||$ 32.80||$ 29.66|
The current last sale of $33.13 is 11.70% Higher thanthe 52 week low.
ETFs with IPXL as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.36%||PowerShares S&P SmallCap Health Care Portfolio (PSCH)||-2.48 (-3.45%)|
|0.93%||Vanguard S&P Small-Cap 600 Growth ETF (VIOG)||-4.37 (-3.93%)|
|0.83%||SPDR S&P 600 Small Cap Growth ETF (based on S&P SmallCap 600 G (SLYG)||-14.62 (-7.78%)|
|0.83%||iShares S&P SmallCap 600 Growth ETF (IJT)||-5.15 (-3.97%)|
|0.47%||Vanguard S&P Small-Cap 600 ETF (VIOO)||-1.58 (-1.51%)|
Company Description (as filed with the SEC)
We are a specialty pharmaceutical company applying formulation and development expertise, as well as our drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products, commonly referred to as "generics," in addition to the development and marketing of branded products. We operate in two segments, referred to as "Impax Generics" and "Impax Specialty Pharma". The Impax Generics division concentrates its efforts on the development, manufacture, sale and distribution of our generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are usually marketed under their established nonproprietary drug names rather than by a brand name. ... More ...
Where does IPXL fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$1.45|
|Quarterly EPS Est:||0.45|